Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study

被引：0
|
作者：
Peng, Chen
Guo, Qiufen
Zhang, Tingting
Chen, Jinlong
Liu, Naifu
Yan, Peile
Lu, Yuanyuan
Ma, Anqun
Lv, Pengzhong
Liu, Jing
Xie, Peng
机构：
[1] Shandong First Med, Shandong Canc Hosp, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[3] Jilin Univ, Dept Gastrointestinal Colorectal & Anal Surg, China Japan Union Hosp, Changchun, Peoples R China
[4] Wannan Med Coll, Dept Radiat Oncol, Affiliated Hosp 1, Wuhan, Peoples R China
[5] Shandong First Med Univ, Dept Thorac Surg, East Hosp, Affiliated Prov Hosp, Jinan, Peoples R China
[6] Shandong First Med Univ, Dept Gynecol, Affiliated Hosp 1, Jinan, Peoples R China
[7] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
[8] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17518
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
    Son, Ji
    Lin, Heather Y.
    Fu, Siqing
    Biter, Amadeo B.
    Dumbrava, Ecaterina E.
    Karp, Daniel D.
    Naing, Aung
    Pant, Shubham
    Piha-Paul, Sarina A.
    Rodon, Jordi
    Subbiah, Vivek
    Tsimberidou, Apostolia M.
    Yap, Timothy A.
    Frumovitz, Michael M.
    Jazaeri, Amir A.
    Ramirez, Pedro T.
    Westin, Shannon N.
    Yuan, Ying
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2023, 6 (01) : 10 - 18
  • [22] A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
    Yang, Hui
    Sun, Shaoxing
    Mei, Zijie
    Xiang, Qingming
    Yang, Chunxu
    Chen, Min
    Xie, Conghua
    Zhou, Yunfeng
    Qiu, Hui
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4665 - 4674
  • [23] A phase II study of atezolizumab in combination with bevacizumab in patients with recurrent, persistent or metastatic cervical cancer
    Friedman, C. F.
    Snyder, A.
    Sharon, E.
    De Meritens, A. Buckley
    Cantrell, L. A.
    Corr, B. R.
    Konner, J.
    Konstantinopoulos, P. A.
    Soldan, K.
    Aghajanian, C. A.
    Zamarin, D.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 17 - 18
  • [24] Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer
    Kim, Tae Hun
    Kim, Moon-Hong
    Kim, Beob-Jong
    Park, Sang-Il
    Ryu, Sang-Young
    Cho, Chul-Koo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (05): : 1124 - 1131
  • [25] Management of patients with metastatic colorectal cancer in Lebanese hospitals and associated direct cost: a multicentre cohort study
    Henaine, Anna Maria
    Chahine, Georges
    Massoud, Marcel
    Salameh, Pascale
    Awada, Sanaa
    Lahoud, Nathalie
    Elias, Edward
    Salem, Mansour
    Ballouts, Souheir
    Hartmann, Daniel
    Aulagner, Gilles
    Armoiry, Xavier
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2019, 25 (07) : 481 - 494
  • [26] The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer
    Minion, Lindsey E.
    Tewari, Krishnansu S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (03) : 191 - 198
  • [27] Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review
    Skelton, William Paul
    Castagno, Jacqueline
    Cardenas-Goicoechea, Joel
    Daily, Karen
    Yeung, Anamaria
    Markham, Merry Jennifer
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [28] Systemic therapy for recurrent, persistent, or metastatic cervical cancer: a clinical practice guideline
    Hirte, H.
    Kennedy, E. B.
    Elit, L.
    Fung, M. Fung Kee
    CURRENT ONCOLOGY, 2015, 22 (03) : 211 - 219
  • [29] apatinib plus capecitabine in patients of recurrent/metastatic and persistent cervical cancer
    Li, J.
    Mao, W.
    Li, F.
    Ran, L.
    Chang, J.
    Mei, F.
    Hu, L.
    Du, Y.
    Tian, X.
    Shan, L.
    Liu, M.
    Chen, Y.
    Mu, J.
    Qin, Y.
    Yin, S.
    Liang, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1073 - S1074
  • [30] Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
    Ercelep, Ozlem
    Tataroglu, Deniz
    Ozcelik, Melike
    Surmeli, Heves
    Degirmenci, Mustafa
    Inanc, Mevlude
    Aliustaoglu, Mehmet
    Gumus, Mahmut
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 17 (02) : 123 - 127
12345